TMEM246-AS1
gene geneOn this page
Summary
TMEM246-AS1 (TMEM246 antisense RNA 1, HGNC:51191) is a long non-coding RNA gene on chromosome 9q31.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:51191 |
| Approved symbol | TMEM246-AS1 |
| Name | TMEM246 antisense RNA 1 |
| Location | 9q31.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000225376 |
| Ensembl biotype | lncRNA |
| Entrez | 101928470 |
| RNAcentral | URS000075EE24 — lncRNA, 565 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 8 lncRNA
ENST00000424154, ENST00000425734, ENST00000431507, ENST00000450109, ENST00000666720, ENST00000749559, ENST00000749560, ENST00000749561
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000424154 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001631559 | 101468398 | 101468608 |
| ENSE00001703907 | 101479840 | 101479923 |
| ENSE00003858404 | 101481363 | 101482199 |
Expression profiles
Bgee: expression breadth ubiquitous, 124 present calls, max score 87.95.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0903 / max 9.5369, expressed in 50 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 97758 | 0.0614 | 38 |
| 205585 | 0.0190 | 9 |
| 97760 | 0.0080 | 4 |
| 97759 | 0.0021 | 2 |
Top tissues by expression
128 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| quadriceps femoris | UBERON:0001377 | 87.95 | gold quality |
| cerebellar vermis | UBERON:0004720 | 85.99 | gold quality |
| corpus callosum | UBERON:0002336 | 84.37 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 80.91 | gold quality |
| kidney | UBERON:0002113 | 78.72 | gold quality |
| bone marrow cell | CL:0002092 | 73.03 | gold quality |
| bone marrow | UBERON:0002371 | 73.03 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 72.06 | silver quality |
| cortex of kidney | UBERON:0001225 | 71.17 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 69.14 | gold quality |
| spinal cord | UBERON:0002240 | 69.12 | gold quality |
| cortical plate | UBERON:0005343 | 68.86 | gold quality |
| right uterine tube | UBERON:0001302 | 68.26 | gold quality |
| primary visual cortex | UBERON:0002436 | 65.76 | gold quality |
| thymus | UBERON:0002370 | 65.75 | silver quality |
| substantia nigra | UBERON:0002038 | 65.58 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 65.40 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 64.76 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 64.75 | gold quality |
| cerebellar cortex | UBERON:0002129 | 64.71 | gold quality |
| cerebellum | UBERON:0002037 | 64.63 | gold quality |
| prefrontal cortex | UBERON:0000451 | 64.10 | gold quality |
| Ammon’s horn | UBERON:0001954 | 63.47 | gold quality |
| apex of heart | UBERON:0002098 | 63.47 | gold quality |
| metanephros cortex | UBERON:0010533 | 63.35 | gold quality |
| adrenal tissue | UBERON:0018303 | 63.23 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 61.73 | gold quality |
| frontal cortex | UBERON:0001870 | 61.24 | gold quality |
| cerebral cortex | UBERON:0000956 | 60.75 | gold quality |
| ventricular zone | UBERON:0003053 | 60.36 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.11 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.